Daily Archives: July 21, 2020
Phase 2 randomized trial: immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults
21 Jul, 2020 | 09:29h | UTCCommentaries: China’s Ad5 vectored COVID-19 vaccine safe and induces immune response – News Medical AND CanSino COVID-19 vaccine generates immune response in 90% of patients – UPI
Related Commentary on Twitter
NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT pic.twitter.com/olXJsOgTFv
— The Lancet (@TheLancet) July 20, 2020
Editorial: encouraging results from phase 1/2 COVID-19 vaccine trials
21 Jul, 2020 | 09:35h | UTCEncouraging results from phase 1/2 COVID-19 vaccine trials – The Lancet
Commentaries: Promising early findings for 2 more COVID-19 vaccines – CIDRAP AND Expert reaction to two vaccine candidate studies: a phase 1/2 trial of the University of Oxford’s ChAdOx1 vaccine candidate; and a phase 2 trial of China’s Ad5-vectored COVID-19 vaccine candidate – Science Media Centre
[Press release-based medicine…] Synairgen announces positive results from trial of SNG001 in hospitalized COVID-19 patients
21 Jul, 2020 | 09:27h | UTCSynairgen announces positive results from trial of SNG001 in hospitalised COVID-19 patients
Commentaries: New Treatment for Covid-19 Shows Promise, but Scientists Urge Caution – The New York Times AND Expert reaction to announcement by Synairgen that their drug SNG001 has had positive results in initial trials on COVID-19 patients – Science Media Centre AND Trial of Covid-19 drug given via inhaler ‘very promising’, say scientists – The Guardian
Phase 1/2 randomized trial: safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2
21 Jul, 2020 | 09:33h | UTCCommentaries: New study reveals Oxford coronavirus vaccine produces strong immune response – University of Oxford AND Oxford’s Covid-19 vaccine appears safe and induces immune response, early results suggest, but more research is needed – CNN AND Early Oxford-AstraZeneca Coronavirus Vaccine Data ‘Encouraging,’ Scientists Say – NPR
Related Commentary on Twitter
NEW—UK’s #COVID19 vaccine is safe and induces an immune reaction, according to preliminary results https://t.co/rDPlB9fDKr pic.twitter.com/z2t9Aubjim
— The Lancet (@TheLancet) July 20, 2020
Survivorship after COVID-19 ICU stay
21 Jul, 2020 | 09:23h | UTCSurvivorship after COVID-19 ICU stay – Nature Reviews
[Preprint] Covid-19: Six clusters of symptoms could be used as a clinical prediction tool
21 Jul, 2020 | 09:25h | UTCCommentaries: Covid-19: Study reveals six clusters of symptoms that could be used as a clinical prediction tool – The BMJ AND Six distinct ‘types’ of COVID-19 identified – King’s College London AND Coronavirus symptoms fall into six different groupings, study finds – The Guardian
Modeling study: impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis
21 Jul, 2020 | 09:19h | UTC
Related Commentary on Twitter
NEW—Disruption to cancer diagnosis services & people avoiding healthcare because of #COVID19 could result in 3500 potentially avoidable deaths from the 4 main cancers in England by 2025: a national, population-based, modelling study @TheLancetOncol https://t.co/kuuNEmcQgt pic.twitter.com/keS43vDF16
— The Lancet (@TheLancet) July 20, 2020
Thrombosis in hospitalized patients with COVID-19 in a New York City health system
21 Jul, 2020 | 09:21h | UTCThrombosis in Hospitalized Patients With COVID-19 in a New York City Health System – JAMA
[Abstract Only] Randomized trial: Dexmedetomidine does not decrease postoperative atrial arrhythmias or delirium in patients recovering from cardiac surgery
21 Jul, 2020 | 09:16h | UTC
Related Commentary on Twitter
DECADE: in 794 cardiac surgery patients, dexmedetomidine vs saline from surgical incision till 24h led to less atrial fibrillation (30% vs 34%, n.s.), but more delirium (17% vs 12%, n.s.), and more serious events (5% vs 1% ns).
Thanks to @CritCareReviews https://t.co/ZGs1ZSGMmP— Peter Nydahl (@NydahlPeter) July 20, 2020
Study: Increased incidence of ketoacidosis in children and adolescents with newly diagnosed Type 1 Diabetes during the COVID-19 pandemic
21 Jul, 2020 | 09:22h | UTC
How (not) to write about global health
21 Jul, 2020 | 09:05h | UTCHow (not) to write about global health – The BMJ Global Health
Related Commentary on Twitter
Great satirical article on the ethics of global health research collaboration and the common faux pas by @desmondtanko #globalhealth #ethics https://t.co/foOcXnK1FY
— Rennie Qin (@RennieQin) July 20, 2020
Guideline: Diagnosing acute aortic syndrome
21 Jul, 2020 | 09:18h | UTCCommentary: New guideline can help clinicians identify hard-to-diagnose acute aortic syndrome – News Medical
Podcast on acute kidney injury: myths & musings
21 Jul, 2020 | 08:59h | UTC#226 Kidney Boy on Acute Kidney Injury: Myths & Musings – The Curbsiders Internal Medicine Podcast
Burnout, a silent crisis in global health
21 Jul, 2020 | 09:00h | UTCBurnout, A Silent Crisis In Global Health – Forbes
Related Commentary from the Author
Burnout, A Silent Crisis In Global Health
This was not easy to write, but I am grateful to over a dozen colleagues who made valuable contributions.
Please read, comment, share, so we can collectively address burnout in global health.https://t.co/EPCknsAvxH via @Forbes pic.twitter.com/LiHIMx6IB7
— Madhu Pai (@paimadhu) July 20, 2020
Tue July 21 – 10 Stories of The Day!
21 Jul, 2020 | 09:36h | UTC
1 – Encouraging results from phase 1/2 COVID-19 vaccine trials – The Lancet
Commentaries: Promising early findings for 2 more COVID-19 vaccines – CIDRAP AND Expert reaction to two vaccine candidate studies: a phase 1/2 trial of the University of Oxford’s ChAdOx1 vaccine candidate; and a phase 2 trial of China’s Ad5-vectored COVID-19 vaccine candidate – Science Media Centre
Commentaries: New study reveals Oxford coronavirus vaccine produces strong immune response – University of Oxford AND Oxford’s Covid-19 vaccine appears safe and induces immune response, early results suggest, but more research is needed – CNN AND Early Oxford-AstraZeneca Coronavirus Vaccine Data ‘Encouraging,’ Scientists Say – NPR
Commentaries: China’s Ad5 vectored COVID-19 vaccine safe and induces immune response – News Medical AND CanSino COVID-19 vaccine generates immune response in 90% of patients – UPI
4 – Synairgen announces positive results from trial of SNG001 in hospitalised COVID-19 patients
Commentaries: New Treatment for Covid-19 Shows Promise, but Scientists Urge Caution – The New York Times AND Expert reaction to announcement by Synairgen that their drug SNG001 has had positive results in initial trials on COVID-19 patients – Science Media Centre AND Trial of Covid-19 drug given via inhaler ‘very promising’, say scientists – The Guardian
Commentaries: Covid-19: Study reveals six clusters of symptoms that could be used as a clinical prediction tool – The BMJ AND Six distinct ‘types’ of COVID-19 identified – King’s College London AND Coronavirus symptoms fall into six different groupings, study finds – The Guardian
6 – Survivorship after COVID-19 ICU stay – Nature Reviews
8 – Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System – JAMA
10 –COVID-19 Updates / 21 July 2020 Edition
21 July 2020 Edition – COVID-19/SARS-CoV-2 Latest Articles, Guidelines, News & Perspectives (several free resources)